CB
Continuity Biosciences, LLC
SEC filingBiotechnology · Bradenton, FL
Amount raised$8.4Msold at filing
Total offering$12M$3.6M still open
Investors in the raise13count reported to the SEC
FiledAug 19, 2025first sale Aug 12, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael L. FowlerDirector
Allen R. WeissDirector
Monica P. ReedDirector
Joseph R. DeSimoneDirector
Ramakrishna VenugopalanExecutive Officer, Director
Robert WhiteheadDirector
Josephine R. TorrenteDirector
Executive officers, directors and promoters as listed on the Form D.